HRP20170011T1 - Postupak za izradu pemetrekseda i njegove lizinske soli - Google Patents

Postupak za izradu pemetrekseda i njegove lizinske soli Download PDF

Info

Publication number
HRP20170011T1
HRP20170011T1 HRP20170011TT HRP20170011T HRP20170011T1 HR P20170011 T1 HRP20170011 T1 HR P20170011T1 HR P20170011T T HRP20170011T T HR P20170011TT HR P20170011 T HRP20170011 T HR P20170011T HR P20170011 T1 HRP20170011 T1 HR P20170011T1
Authority
HR
Croatia
Prior art keywords
pemetrexed
lysine
salt
acid
ethyl
Prior art date
Application number
HRP20170011TT
Other languages
English (en)
Croatian (hr)
Inventor
Fabrizio Bonaccorsi
Federico Calvani
Franco Pasqui
Original Assignee
Berlin-Chemie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin-Chemie Ag filed Critical Berlin-Chemie Ag
Publication of HRP20170011T1 publication Critical patent/HRP20170011T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HRP20170011TT 2012-08-08 2013-08-08 Postupak za izradu pemetrekseda i njegove lizinske soli HRP20170011T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000398A ITRM20120398A1 (it) 2012-08-08 2012-08-08 Procedimento di sintesi pemetrexed e suo sale di lisina.
PCT/IB2013/056497 WO2014024164A1 (en) 2012-08-08 2013-08-08 Process for the preparation of pemetrexed and lysin salt thereof
EP13777144.0A EP2882753B1 (en) 2012-08-08 2013-08-08 Process for the preparation of pemetrexed and lysin salt thereof

Publications (1)

Publication Number Publication Date
HRP20170011T1 true HRP20170011T1 (hr) 2017-03-10

Family

ID=47018368

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20170011TT HRP20170011T1 (hr) 2012-08-08 2013-08-08 Postupak za izradu pemetrekseda i njegove lizinske soli

Country Status (23)

Country Link
EP (1) EP2882753B1 (2)
KR (1) KR102288417B1 (2)
CN (1) CN104736540B (2)
AU (1) AU2013301156B2 (2)
BR (1) BR112015002429A8 (2)
CY (1) CY1118514T1 (2)
DK (1) DK2882753T3 (2)
ES (1) ES2607890T3 (2)
HR (1) HRP20170011T1 (2)
HU (1) HUE032304T2 (2)
IN (1) IN2015DN00833A (2)
IT (1) ITRM20120398A1 (2)
LT (1) LT2882753T (2)
MX (1) MX362858B (2)
PL (1) PL2882753T3 (2)
PT (1) PT2882753T (2)
RS (1) RS55515B1 (2)
RU (1) RU2609006C2 (2)
SI (1) SI2882753T1 (2)
SM (2) SMT201600474T1 (2)
TW (1) TWI609017B (2)
WO (1) WO2014024164A1 (2)
ZA (1) ZA201501549B (2)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107641124A (zh) * 2016-07-22 2018-01-30 上海创诺制药有限公司 一种培美曲塞二酸新晶型及其制备方法
CN109836425B (zh) * 2017-11-24 2023-01-24 江苏创诺制药有限公司 一种合成培美酸的制备工艺
EP3749317A4 (en) 2018-02-07 2022-06-22 L.E.A.F Holdings Group LLC PEMETREXED ALPHA-POLYGLUTAMATE AND ASSOCIATED USES
US12246018B2 (en) 2018-02-07 2025-03-11 L.E.A.F. Holdings Group Llc Gamma polyglutamated pemetrexed and uses thereof
CN110128427A (zh) * 2018-02-09 2019-08-16 鲁南制药集团股份有限公司 培美曲塞缬氨酸盐
CN110128426B (zh) * 2018-02-09 2021-12-14 鲁南制药集团股份有限公司 培美曲塞谷氨酸盐
CN110128428A (zh) * 2018-02-09 2019-08-16 鲁南制药集团股份有限公司 培美曲塞丙氨酸盐
CN111333658A (zh) * 2020-05-06 2020-06-26 贵州联科中贝制药科技有限公司 一种培美曲塞二钠水合物的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0440795B1 (en) 1988-10-31 1994-10-19 MITSUI TOATSU CHEMICALS, Inc. Process for preparing organic group-substituted sodium aluminum hydride
KR0162654B1 (ko) 1989-12-11 1998-11-16 알렌 제이. 시니스갤리 N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체
IL96531A (en) 1989-12-11 1995-08-31 Univ Princeton History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them)
CZ283281B6 (cs) * 1992-09-25 1998-02-18 Eli Lilly And Company Způsob přípravy v poloze 5 substituovaných pyrrolo(2,3-d)pyrimidinů
US5416211A (en) 1992-09-25 1995-05-16 Eli Lilly And Company Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
DE19725647A1 (de) 1997-06-18 1998-12-24 Basf Ag Cyclopenta[I]phenanthren-Metallkomplex-Katalysatorsysteme
ZA987550B (en) 1997-09-26 2000-02-21 Lilly Co Eli Processes and intermediates useful to make antifolates.
IL150480A0 (en) 2000-02-25 2002-12-01 Lilly Co Eli A NOVEL-CRYSTALLINE FORM OF N-[4-[2-(2-AMINO-4, 7-DIHYDRO-4-OXO-3H-PYRROLO[2, 3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR
JP2008543973A (ja) 2006-08-14 2008-12-04 シコール インコーポレイティド ペメトレキセドの中間体の調製方法
JP2008543975A (ja) * 2006-08-14 2008-12-04 シコール インコーポレイティド 高度に純粋なペメトレキセド二酸およびその調製方法
CN101591247B (zh) * 2008-05-30 2012-09-05 上海希迪制药有限公司 合成4-(4-甲酯基苯基)丁醛的方法
IT1401677B1 (it) * 2010-07-22 2013-08-02 Chemi Spa Nuovo processo per la sintesi di pemetrexed sale disodico
US9655898B2 (en) 2010-07-28 2017-05-23 Eagle Pharmaceuticals, Inc. Pharmaceutical compositions containing pemetrexed having extended storage stability
WO2012056285A1 (en) * 2010-10-25 2012-05-03 Fresenius Kabi Oncology Ltd. An improved process for the preparation of pemetrexed

Also Published As

Publication number Publication date
SI2882753T1 (sl) 2017-02-28
BR112015002429A2 (pt) 2017-07-04
CN104736540A (zh) 2015-06-24
PT2882753T (pt) 2016-12-27
IN2015DN00833A (2) 2015-06-12
HK1209426A1 (en) 2016-04-01
ES2607890T3 (es) 2017-04-04
EP2882753A1 (en) 2015-06-17
PL2882753T3 (pl) 2017-04-28
AU2013301156B2 (en) 2017-08-31
SMT201600474T1 (it) 2017-03-08
WO2014024164A1 (en) 2014-02-13
RS55515B1 (sr) 2017-05-31
MX362858B (es) 2019-02-20
EP2882753B1 (en) 2016-10-05
HUE032304T2 (en) 2017-09-28
RU2015108042A (ru) 2016-09-27
BR112015002429A8 (pt) 2019-07-30
TW201412741A (zh) 2014-04-01
KR102288417B1 (ko) 2021-08-11
LT2882753T (lt) 2016-12-12
TWI609017B (zh) 2017-12-21
KR20150045458A (ko) 2015-04-28
CN104736540B (zh) 2017-08-25
SMT201600474B (it) 2017-03-08
DK2882753T3 (en) 2017-01-16
MX2015001712A (es) 2015-08-14
CY1118514T1 (el) 2017-07-12
ITRM20120398A1 (it) 2014-02-09
ZA201501549B (en) 2016-01-27
RU2609006C2 (ru) 2017-01-30
AU2013301156A1 (en) 2015-02-05

Similar Documents

Publication Publication Date Title
RU2015108042A (ru) Способ получения пеметрекседа и его лизиновой соли
ES2534096T3 (es) Derivados de piridina y pirazina bicíclicos condensados como inhibidores de quinasa
KR101591153B1 (ko) Trpa1 길항제로서의 2-아미노-4-아릴티아졸 화합물
ES2779225T3 (es) Reactivos de merilformilo sustituido y procedimiento de uso de los mismos para modificar propiedades fisicoquímicas y/o farmacocinéticas de compuestos
ES2751491T3 (es) Derivados de purina como moduladores de la actividad de TNF
CA2707521A1 (en) Imidazopyrazine compounds
CA2673965A1 (en) Pyrazolopyrimidine compound
ES2642720T3 (es) Derivados de 1,5-naftiridina como inhibidores de MELK
BR112020007593A2 (pt) derivados de imidazol condensados substituídos por grupos hidróxi terciários como inibidores de pi3k-gama
CA3234823A1 (en) A synthesis scheme and procedures for preparing a sik3 inhibitor and intermediates thereof
AU2022253683A1 (en) Deuterated dhodh inhibitors
JP2015531399A (ja) 新規な化合物、それらの調製及びそれらの使用
ES2819249T3 (es) Derivados de tetrahidroimidazopiridina como moduladores de la actividad de TNF
ITMI20011764A1 (it) Metodo per l'ottenimento del pemirolast ad elevata purezza
ES2553834T3 (es) Un nuevo método para producir agentes antifolatos que tienen ácido glutámico como parte de su estructura
DE602004008486T2 (de) Verfahren zur herstellung von (1s,4r)-cis-4-ä2-amino-6-chlor-9h-purin-9-ylü-2-cyclopenten-1-methanol
CN1898245B (zh) 三唑嘧啶的制备方法
US8952153B2 (en) One pot process for preparing pemetrexed disodium
MXPA06007400A (es) Proceso para la preparacion de triazolopirimidinas
HK1209426B (en) Process for the preparation of pemetrexed and lysin salt thereof
ITMI20080580A1 (it) Acido ibandronico non solvatato ad elevata purezza, suo impiego per la preparazione di ibandronato sodico amorfo e procedimento per la sua preparazione